Carmoterol

DB15784InvestigationalSmall molecule

Carmoterol is a long acting beta-2 agonist indicated in the treatment of COPD, asthma, and chronic bronchitis.

Chemical structure of Carmoterol
Mechanism
Curator reviewed
Formula / weight
C21H24N2O4 · 368.433 g/mol (avg)
Also known as
Quinoterol
Code names
CHF-4226 · TA-2005

Resolves to

Compound
UNII9810NUL4D1CAS147568-66-9ChEMBLCHEMBL1094785
Structure
InChIKeyIHOXNOQMRZISPV-YJYMSZOUSA-NSMILESCOC1=CC=C(C[C@@H](C)NC[C@H](O)C2=CC=C(O)C3=C2C=CC(=O)N3)C=C1
Targets
P07550ADRB2

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
10Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
33Marketed productsAcross 1 country and 2 labellers
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Carmoterol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In